期刊文献+

兔VX2肝癌高能聚焦超声治疗后的磁共振灌注加权成像 被引量:5

MR perfusion-weighted imaging in rabbit models of hepatic VX2 tumors after high intensity focused ultrasound
下载PDF
导出
摘要 目的探讨高能聚焦超声(HIFU)治疗兔VX2肝癌后的磁共振灌注加权成像(PWI)的成像技术及特征。方法新西兰大白兔20只,平均随机分成治疗组与对照组,制作肝癌模型。瘤株接种2周后进行常规MR及PWI扫描。此后治疗组行HIFU单次治疗,14d后对两组均行PWI检查,选取病灶与周围正常肝组织的感兴趣区(ROI),采用信号强度-时间曲线的最大信号下降斜率(SRSmax)作为定量指标,分析不同ROI的SRSmax下降程度及规律。结果对照组肿瘤中央区与瘤旁肝实质SRSmax的差异无统计学意义,治疗组内VX2瘤中央区、周边区及瘤旁肝实质SRSmax的差异均有统计学意义。治疗组与对照组肿瘤周边区SRSmax的差异有统计学意义。结论兔肝VX2瘤PWI表现与肿瘤坏死程度、范围基本相符,PWI可用于评价HIFU治疗后肝脏肿瘤的血管生成、破坏状况。 Objective To evaluate the imaging features of perfusion-weighted imaging (PWI) in the rabbit VX2 liver cancer after HIFU therapy. Methods Twenty New Zealand rabbits were randomly divided into treatment and control groups. Routine MR and PWI examinations were performed 2 weeks after tumor strain planted. After that, rabbits in the treatment group underwent HIFU treatment. PWI was performed after treatment in both groups 14 d after HIFU treatment in treatment group. ROls of lesions and near normal tissue were selected to test the blood flow value. Maximal signal reduction slope (SRSmax) was used as a quantitative parameter during PWI. Results Significant difference of SRSmax was found among center zone of tumor, peripheral zone and surrounding liver parenchyma in treatment group, also in the peripheral zone of tumor between treatment group and control group, but not between central and peripheral area of tumor in the treatment group. Conclusion PWI findings are basically consistant with tumor necrosis level and extent. PWI can be used to evaluate the formation and destroy of blood vessel after the HIFU treatment of liver tumor in rabbits.
出处 《中国医学影像技术》 CSCD 北大核心 2009年第6期949-952,共4页 Chinese Journal of Medical Imaging Technology
基金 广州市卫生局医药科技项目(2007-YB-033)
关键词 肝肿瘤 磁共振成像 灌注 动物 Liver neoplasms Magnetic resonance imaging Perfusion Animal
  • 相关文献

参考文献5

二级参考文献44

  • 1严惠芳 傅方君 等.可移植性动物肿瘤株的冻存和复苏[J].医药工业,1986,17(10):28-29.
  • 2Weidner N,Barbarishi M,Gasparini G,et al.Microvascular density qualification in breast carcinoma[J].Applied Immunhistochemistry,1995,3(2):75-79.
  • 3Zagzag A,Brem S,Robert F,et al.Neovascularization and tumor growth in the rabbit brain[J].Am J Pathol,1988,131 (2):361-372.
  • 4Boehm T,Malich A,Goldberg SN,et al.Radio-frequency tumor ablation:internally cooled electrode versus saline-enhanced technique in an aggressive rabbit tumor model[J].Radiology,2002,222(3):805-813.
  • 5Carson BS,Anderson JH,Grossman SA,et al.Improved rabbit brain tumor model amenable to diagnostic radiographic procedures[J].Neurosurgery,1982,11(5):603-608.
  • 6Hermans R,Lambin P.Non-invasive tumor perfusion measurement by dynamic CT:preliminary results[J].Radiother Oncol,1997,44(2):159-168.
  • 7Swistel AJ,Bading JR,Raaf JH,et al.Intraarterial versus intravenous adriamycin in the rabbit VX2 tumor system[J].Cancer,1984,53(6):1397-1404.
  • 8Tabaru K,Konno T,Oda T,et al.Treatment of VX2 carcinoma implanted in the liver with arterial and intraperitoneal administration of oily anticancer agents[J].Cancer Chemother Pharmacol,2001,47(2):149-154.
  • 9Hamuro M,Nakamura K,Sakai Y,et al.New oily agents for targeting chemoembolization for hepatocellular carcinoma[J].Cardiovasc Intervent Radiol,1999,22(2):130-134.
  • 10Yamada K,Wu O,Gonzalez RG,et al.Magnetic resonance perfusion-weighted imaging of acute cerebral infarction:effect of the calculation methods and underlying vasculopathy[J].Stroke,2002,33(1):87 -94.

共引文献95

同被引文献36

  • 1张景峰,王仁法,宋金梅,李勇刚,张菁,王敏华.兔VX2软组织肿瘤模型的建立与MSCT灌注成像研究[J].中国医学影像学杂志,2004,12(6):441-444. 被引量:7
  • 2姜慧杰,徐克,韩铭钧,戴旭,黄奇,李大庆,黄亚华.CT灌注成像对兔肝肿瘤模型血管生成的定量研究[J].中国医学影像技术,2006,22(11):1625-1628. 被引量:5
  • 3Hong K, Geordiades CS, Geschwind JF. Technology insight: imageguided therapies for hepatocellular carcinomaintraarterial and ablative techniques. Nat Clin Pract Oncol, 2006,3 (6) : 315-324.
  • 4Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early stage hepatocellular carcinoma as a firstqinetreatment: longterm results and prognostic factors in a large singleinstitution series. Eur Radiol, 2007,17 (3) : 684-692.
  • 5Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology, 2000,214(3) :761-768.
  • 6Kei SK, Rhim H, Choi D, et al. Local tumor progression after radio frequency ablation of liver tumors: analysis of morphologic pattern and sit e of recurrence. A JR Am J Roentgenol, 2008, 190 ( 6 ) : 1544-1551.
  • 7Catalano O, Lobianco R, Esposito M, et al. Hepatocellular carcinoma recurrence after percutaneous ablation therapy: helical CT patterns. Abdom Imaging, 2001,26 (4) : 375 383.
  • 8Goldberg SN, Charboneau JW, Dodd GD 3rd, et al. Imageguided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology, 2003,228(2):335-345.
  • 9Nakazawa T, Kokubu S, Shibuya A, et al. Radiofrequeney abla lion of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol, 2007, 188(2) :480 488.
  • 10Hori T, Nagata K, Hasuike S, et al. Risk factors forthe local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterot, 2003, 38 (10) :977-981.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部